+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
Healthy Volunteers
ID05876312

Phase 1 and Phase 2a Study of ADX-038 to Assess Safety and Effects in Healthy Adults and Patients with Paroxysmal Nocturnal Hemoglobinuria

Led by ADARx Pharmaceuticals, Inc. · Updated on 2026-06-16

50

Participants Needed

4

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a Phase 1Phase 2a study to evaluate the safety, tolerability, pharmacokinetics PK, and pharmacodynamics PD of ADX-038, a siRNA duplex oligonucleotide drug. The study involves both healthy participants and patients with paroxysmal nocturnal hemoglobinuria PNH, a condition characterized by residual anemia despite standard anti-C5 treatment. The purpose is to assess how the drug behaves in the body and its safety in these two groups. The study has two parts Phase 1 is a randomized, double-blind, placebo-controlled, single ascending dose trial in healthy participants with up to five dose cohorts. Phase 2a is an open-label, single-arm study where PNH patients on stable anti-C5 regimens receive ADX-038 at doses determined from Phase 1 results. In Phase 1, participants are randomized to receive either ADX-038 or placebo, with initial safety assessment through sentinel dosing. Participants will undergo medical evaluations, safety monitoring, and laboratory testing throughout the study. Healthy participants will be observed for safety and drug behavior up to 365 days, while PNH patients will be followed for safety and pharmacodynamics for the same duration. Researchers will measure treatment safety, tolerability, and drug effects using various clinical and laboratory assessments during and after dosing. The entire study may last up to several years, with detailed follow-up to understand ADX-038s profile.

CONDITIONS

Brief Title

Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Research Team

S

Stephanie Leyva

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here